Cetera Advisors’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,945	Closed	-$507K	–	1756
2023 Q1	$507K	Buy	+19,945	New	+$507K	0.01%	1002